Intelligence Profile
Clinical Applications
Haelan 951 is a soy-based flavonoid beverage investigated for various clinical applications, including muscle-related disorders, cancer, and menopause symptoms.
Duchenne Muscular Dystrophy (DMD): A study published in PLoS Currents (2018) explored the efficacy of soy products, including Haelan 951, in DMD. While the details on outcomes are limited, soy products were hypothesized to support muscle health due to their anti-inflammatory properties.
Cancer: Research in BMC Complementary and Alternative Medicine (2015) reported that Haelan 951 can induce growth arrest and apoptosis in pancreatic cancer cell lines. This in vitro study suggests potential antitumor properties, though clinical efficacy in humans requires further investigation.
Menopause: An upcoming clinical trial (NCT07751029) aims to explore Haelan 951's effects on symptoms in peri- and postmenopausal women. As recruitment has not yet begun, no clinical data are currently available.
Overall, while initial studies show promise for Haelan 951 in various conditions, comprehensive clinical evidence is still needed to confirm these applications.
Disclaimer: This summary is for informational purposes only and not a substitute for professional medical advice.